您的位置: 首页 > 农业专利 > 详情页

rotigotine (neupro and pharmaceutically acceptable derivatives thereof.
专利权人:
UCB Biopharma SPRL;LTS Lohmann Therapie-Systeme AG
发明人:
MÜLLER Walter,PECK James, V.
申请号:
LU91269
公开号:
LU91269I9
申请日:
2006.07.26
申请国别(地区):
LU
年份:
2018
代理人:
摘要:
A transdermal therapeutic system, comprising a backing layer inert to the components of the matrix, a self-adhesive matrix layer containing (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol in an effective amount and a protective foil or sheet to be removed prior to use, is characterised by a matrix that is based on a non-aqueous, acrylate-based or silicone-based polymer adhesive system having a solubility of >;=5% (w/w) for (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]-amino]-1-naphthalenol, and said matrix is substantially free of inorganic silicate particulates.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充